Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) announced the pricing of an underwritten public offering of common stock consisting of 6,900,000 shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE